Search
for
Sort by
Research 31–60 of 676
- A Prospective, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of a Cream Containing Xyloglucan, Pea Protein, and <i>Opuntia ficus-indica</i> Extract Versus Calcipotriol/Betamethasone in Adult Patients with Mild-to-moderate Psoriasis.
- Evaluation of the effect of topical calcipotriol versus platelet-rich plasma versus a combination of both on patients with Alopecia Areata
- Topical calcipotriol mixed with topical steroid versus topical steroid alone in treatment of alopecia areata
- Alternate treatment of alopecia areata with the use of calcipotriol: A prospective study in children versus adults
- A single topical application of calcipotriol (50μg/g) ointment has no acute effect on systemic calcium homeostasis in patients with chronic plaque psoriasis
- Calcipotriol/dithranol
- En Coup de Sabre in a Pediatric Patient Treated With Calcipotriene
- Combination of topical anthralin and calcipotriene in alopecia areata: A discussion of the mechanisms of action
- Calcitriol-Resistant Rickets With Alopecia
- Calcipotriene/betamethasone in the treatment of psoriasis: a review article
- Eruptive vellus hair cysts: report of a pediatric case with partial response to calcipotriene therapy.
- Calcitriol-resistant rickets with alopecia
- Oral calcitriol in the treatment of scleroderma 'en coupe de sabre'
- Calcitriol ointment in the treatment of facial, hairline and retroauricular chronic plaque psoriasis
- A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).
- Patient and Clinician‐Reported Outcomes and Adherence to Calcipotriene/Betamethasone Dipropionate PAD‐Cream in Treatment of Scalp Psoriasis in Adults: An Interim Analysis of the PRO‐SCALP Study
- Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results.
- A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results
- Effects of calcitriol combined with metformin in the treatment of polycystic ovary syndrome and its influence on serum monocyte chemotactic factor -1
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- Calcitriol and Alopecia—Is it the <i>Hair</i> Apparent?
- Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study
- Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial
- Successful Treatment of Alopecia Totalis with Topical Calcipotriol: Serial Case Report and Review of the Literature
- Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study.
- Psoriasis of the Scalp
- Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas
- Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications
- 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D3 analogue in humans
- Treatments for alopecia areata: A systematic review and network meta‐analysis